Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJJ13
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,932
Award facts
- Contract value 100% obligated
- $27,931.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,931.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Gemtesa 75 mg tablets, with an ultimate completion date of August 12, 2025. This non-set-aside competitive award was issued on August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used to treat overactive bladder, representing one component of the pharmaceutical supplies DLA procures for military healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's status as a major pharmaceutical distributor and its successful track record of fulfilling federal medical procurement requirements through open competition positions it as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJJ13?
SPE2DB25FJJ13 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FJJ13 worth?
The government has obligated $27,932 on SPE2DB25FJJ13.
Is contract SPE2DB25FJJ13 an order under another contract?
Yes. SPE2DB25FJJ13 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ13 competed?
The extent of competition for SPE2DB25FJJ13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award